Jazz Pharma Plc (JAZZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 2,363,567 | 2,161,761 | 1,890,922 | 1,618,693 | 1,487,973 |
| Cost of Goods | 148,917 | 127,930 | 121,544 | 110,188 | 105,386 |
| Gross Profit | 2,214,650 | 2,033,831 | 1,769,378 | 1,508,505 | 1,382,587 |
| Operating Expenses | 1,837,494 | 1,502,387 | 1,155,084 | 979,851 | 791,319 |
| Operating Income | 378,073 | 532,374 | 614,838 | 528,842 | 591,654 |
| Interest Expense | 99,707 | 72,261 | 78,500 | 77,756 | 61,942 |
| Other Income | -6,233 | -9,900 | -9,078 | -10,978 | 2,355 |
| Pre-tax Income | 272,133 | 450,213 | 527,260 | 440,108 | 532,067 |
| Income Tax | 33,517 | -73,154 | 80,162 | -47,740 | 135,236 |
| Net Income Continuous | 238,616 | 523,367 | 447,098 | 487,848 | 396,831 |
| Net Income | $238,616 | $523,367 | $447,098 | $487,848 | $396,831 |
| EPS Basic Total Ops | 4.28 | 9.22 | 7.45 | 8.13 | 6.56 |
| EPS Basic Continuous Ops | 4.28 | 9.22 | 7.45 | 8.13 | 6.56 |
| EPS Diluted Total Ops | 4.22 | 9.09 | 7.30 | 7.96 | 6.41 |
| EPS Diluted Continuous Ops | 4.22 | 9.09 | 7.30 | 7.96 | 6.41 |
| EPS Diluted Before Non-Recurring Items | 10.77 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $656,326 | $902,530 | $875,529 | $724,022 | $727,567 |